Pages that link to "Q87706687"
Jump to navigation
Jump to search
The following pages link to Celia A. Schiffer (Q87706687):
Displaying 50 items.
- Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces (Q24599263) (← links)
- First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G (Q24615552) (← links)
- Simultaneously Targeting the NS3 Protease and Helicase Activities for More Effective Hepatitis C Virus Therapy (Q26700073) (← links)
- REdiii: a pipeline for automated structure solution (Q27317992) (← links)
- Lack of synergy for inhibitors targeting a multi-drug-resistant HIV-1 protease (Q27637329) (← links)
- Structure of a phage display-derived variant of human growth hormone complexed to two copies of the extracellular domain of its receptor: evidence for strong structural coupling between receptor binding sites (Q27637872) (← links)
- Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes (Q27638967) (← links)
- Viability of a drug-resistant human immunodeficiency virus type 1 protease variant: structural insights for better antiviral therapy (Q27640250) (← links)
- Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands (Q27643226) (← links)
- Design of mutation-resistant HIV protease inhibitors with the substrate envelope hypothesis (Q27645065) (← links)
- Crystal Structure of Lysine Sulfonamide Inhibitor Reveals the Displacement of the Conserved Flap Water Molecule in Human Immunodeficiency Virus Type 1 Protease (Q27646453) (← links)
- Design and Synthesis of HIV-1 Protease Inhibitors Incorporating Oxazolidinones as P2/P2‘ Ligands in Pseudosymmetric Dipeptide Isosteres (Q27647177) (← links)
- Computational design and experimental study of tighter binding peptides to an inactivated mutant of HIV-1 protease (Q27647665) (← links)
- HIV-1 Protease Inhibitors from Inverse Design in the Substrate Envelope Exhibit Subnanomolar Binding to Drug-Resistant Variants (Q27650325) (← links)
- Structural Analysis of Human Immunodeficiency Virus Type 1 CRF01_AE Protease in Complex with the Substrate p1-p6 (Q27650434) (← links)
- Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5 (Q27652424) (← links)
- Evaluating the Substrate-Envelope Hypothesis: Structural Analysis of Novel HIV-1 Protease Inhibitors Designed To Be Robust against Drug Resistance (Q27660267) (← links)
- The Effect of Clade-Specific Sequence Polymorphisms on HIV-1 Protease Activity and Inhibitor Resistance Pathways (Q27663608) (← links)
- Structure-Based Design, Synthesis, and Structure−Activity Relationship Studies of HIV-1 Protease Inhibitors Incorporating Phenyloxazolidinones (Q27665164) (← links)
- Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding (Q27665956) (← links)
- Molecular Mechanisms of Viral and Host Cell Substrate Recognition by Hepatitis C Virus NS3/4A Protease (Q27667503) (← links)
- The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors (Q27671640) (← links)
- TMC310911, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor, Shows In Vitro an Improved Resistance Profile and Higher Genetic Barrier to Resistance Compared with Current Protease Inhibitors (Q27673331) (← links)
- Structural and Thermodynamic Basis of Amprenavir/Darunavir and Atazanavir Resistance in HIV-1 Protease with Mutations at Residue 50 (Q27676079) (← links)
- Hydrophobic Core Flexibility Modulates Enzyme Activity in HIV-1 Protease (Q27676981) (← links)
- Crystal Structure of the DNA Cytosine Deaminase APOBEC3F: The Catalytically Active and HIV-1 Vif-Binding Domain (Q27678176) (← links)
- Structural, kinetic, and thermodynamic studies of specificity designed HIV-1 protease (Q27678853) (← links)
- Substrate Envelope-Designed Potent HIV-1 Protease Inhibitors to Avoid Drug Resistance (Q27679880) (← links)
- Design, Synthesis, and Biological and Structural Evaluations of Novel HIV-1 Protease Inhibitors To Combat Drug Resistance (Q27681219) (← links)
- Extreme Entropy–Enthalpy Compensation in a Drug-Resistant Variant of HIV-1 Protease (Q27681237) (← links)
- Crystal structures of human CtBP in complex with substrate MTOB reveal active site features useful for inhibitor design (Q27682367) (← links)
- HIV-1 Protease-Substrate Coevolution in Nelfinavir Resistance (Q27683192) (← links)
- Drug Resistance Conferred by Mutations Outside the Active Site through Alterations in the Dynamic and Structural Ensemble of HIV-1 Protease (Q27684933) (← links)
- Structural and Thermodynamic Effects of Macrocyclization in HCV NS3/4A Inhibitor MK-5172 (Q27703170) (← links)
- Competition between Ski and CREB-binding protein for binding to Smad proteins in transforming growth factor-beta signaling (Q28286989) (← links)
- Efficient Computation of Small-Molecule Configurational Binding Entropy and Free Energy Changes by Ensemble Enumeration (Q28391043) (← links)
- Influenza virus drug resistance: a time-sampled population genetics perspective (Q28540172) (← links)
- Quantitative comparison of errors in 15N transverse relaxation rates measured using various CPMG phasing schemes (Q28833810) (← links)
- Structural and molecular analysis of a protective epitope of Lyme disease antigen OspA and antibody interactions (Q30395341) (← links)
- Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease (Q30850215) (← links)
- Mass spectrometry analysis of HIV-1 Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity (Q33289183) (← links)
- Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity (Q33630551) (← links)
- Toward the design of mutation-resistant enzyme inhibitors: further evaluation of the substrate envelope hypothesis (Q33815097) (← links)
- Decomposing the energetic impact of drug resistant mutations in HIV-1 protease on binding DRV. (Q33899351) (← links)
- Drug Resistance Mutations Alter Dynamics of Inhibitor-Bound HIV-1 Protease. (Q34045028) (← links)
- Viral protease inhibitors (Q34892265) (← links)
- Modulation of HIV protease flexibility by the T80N mutation (Q35706925) (← links)
- Interdependence of Inhibitor Recognition in HIV-1 Protease. (Q36327966) (← links)
- Citrullination of NF-κB p65 promotes its nuclear localization and TLR-induced expression of IL-1β and TNFα. (Q38636880) (← links)
- Three Residues in HIV-1 Matrix Contribute to Protease Inhibitor Susceptibility and Replication Capacity (Q39621109) (← links)